TY  - GEN
AU  - Mathews,D J H
AU  - Sugarman,J
AU  - Bok,H
AU  - Blass,D M
AU  - Coyle,J T
AU  - Duggan,P
AU  - Finkel,J
AU  - Greely,H T
AU  - Hillis,A
AU  - Hoke,A
AU  - Johnson,R
AU  - Johnston,M
AU  - Kahn,J
AU  - Kerr,D
AU  - Kurtzberg,J
AU  - Liao,S M
AU  - McDonald,J W
AU  - McKhann,G
AU  - Nelson,K B
AU  - Rao,M
AU  - Regenberg,A
AU  - Siegel,A W
AU  - Smith,K
AU  - Solter,D
AU  - Song,H
AU  - Vescovi,A
AU  - Young,W
AU  - Gearhart,J D
AU  - Faden,R
TI  - Cell-based interventions for neurologic conditions: ethical challenges for early human trials
SN  - 1526-632X
PY  - 2008///0902
KW  - Animals
KW  - Biomedical Research
KW  - ethics
KW  - Brain Diseases
KW  - therapy
KW  - Cell- and Tissue-Based Therapy
KW  - Clinical Trials Data Monitoring Committees
KW  - standards
KW  - Clinical Trials as Topic
KW  - Ethics Committees, Research
KW  - Humans
KW  - Neurology
KW  - Risk Assessment
KW  - Stem Cell Transplantation
KW  - Time Factors
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1212/01.wnl.0000316436.13659.80
ER  -